These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 37443154)

  • 1. ACTL6A protects gastric cancer cells against ferroptosis through induction of glutathione synthesis.
    Yang Z; Zou S; Zhang Y; Zhang J; Zhang P; Xiao L; Xie Y; Meng M; Feng J; Kang L; Lee MH; Fang L
    Nat Commun; 2023 Jul; 14(1):4193. PubMed ID: 37443154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACTL6a enforces the epidermal progenitor state by suppressing SWI/SNF-dependent induction of KLF4.
    Bao X; Tang J; Lopez-Pajares V; Tao S; Qu K; Crabtree GR; Khavari PA
    Cell Stem Cell; 2013 Feb; 12(2):193-203. PubMed ID: 23395444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LTBP2 Knockdown Promotes Ferroptosis in Gastric Cancer Cells through p62-Keap1-Nrf2 Pathway.
    Wang T; Zhou Z; Wang C; Qin Y; Wu L; Hu B; Jin Q; Wei W; Huang M
    Biomed Res Int; 2022; 2022():6532253. PubMed ID: 35968244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased ACTL6A occupancy within mSWI/SNF chromatin remodelers drives human squamous cell carcinoma.
    Chang CY; Shipony Z; Lin SG; Kuo A; Xiong X; Loh KM; Greenleaf WJ; Crabtree GR
    Mol Cell; 2021 Dec; 81(24):4964-4978.e8. PubMed ID: 34687603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACTL6A deficiency induces apoptosis through impairing DNA replication and inhibiting the ATR-Chk1 signaling in glioblastoma cells.
    Hu X; Pei D; Ci M; Zhang G; Li B; Wang J; Shen Y; Zhai X; Liang P; Cui H
    Biochem Biophys Res Commun; 2022 Apr; 599():148-155. PubMed ID: 35182941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACTL6A promotes repair of cisplatin-induced DNA damage, a new mechanism of platinum resistance in cancer.
    Xiao Y; Lin FT; Lin WC
    Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33408251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astragaloside-IV alleviates high glucose-induced ferroptosis in retinal pigment epithelial cells by disrupting the expression of miR-138-5p/Sirt1/Nrf2.
    Tang X; Li X; Zhang D; Han W
    Bioengineered; 2022 Apr; 13(4):8240-8254. PubMed ID: 35302431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug resistance-associated protein 1 mediates 15-deoxy-Δ(12,14)-prostaglandin J2-induced expression of glutamate cysteine ligase expression via Nrf2 signaling in human breast cancer cells.
    Song NY; Kim DH; Kim EH; Na HK; Kim NJ; Suh YG; Surh YJ
    Chem Res Toxicol; 2011 Aug; 24(8):1231-41. PubMed ID: 21728338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased glutathione synthesis following Nrf2 activation by vanadyl sulfate in human chang liver cells.
    Kim AD; Zhang R; Kang KA; You HJ; Hyun JW
    Int J Mol Sci; 2011; 12(12):8878-94. PubMed ID: 22272109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACTL6A suppresses p21
    Shrestha S; Adhikary G; Xu W; Kandasamy S; Eckert RL
    Oncogene; 2020 Sep; 39(36):5855-5866. PubMed ID: 32616890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quercetin induces ferroptosis in gastric cancer cells by targeting SLC1A5 and regulating the p-Camk2/p-DRP1 and NRF2/GPX4 Axes.
    Ding L; Dang S; Sun M; Zhou D; Sun Y; Li E; Peng S; Li J; Li G
    Free Radic Biol Med; 2024 Mar; 213():150-163. PubMed ID: 38190923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACTL6A Is Co-Amplified with p63 in Squamous Cell Carcinoma to Drive YAP Activation, Regenerative Proliferation, and Poor Prognosis.
    Saladi SV; Ross K; Karaayvaz M; Tata PR; Mou H; Rajagopal J; Ramaswamy S; Ellisen LW
    Cancer Cell; 2017 Jan; 31(1):35-49. PubMed ID: 28041841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actin-like Protein 6A Expression Correlates with Cancer Stem Cell-like Features and Poor Prognosis in Ovarian Cancer.
    Chen PM; Wong CN; Wong CN; Chu PY
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACTL6A expression promotes invasion, metastasis and epithelial mesenchymal transition of colon cancer.
    Zeng Z; Yang H; Xiao S
    BMC Cancer; 2018 Oct; 18(1):1020. PubMed ID: 30348114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actin-like 6A enhances the proliferative and invasive capacities of laryngeal squamous cell carcinoma by potentiating the activation of YAP signaling.
    Dang Y; Zhang L; Wang X
    J Bioenerg Biomembr; 2020 Dec; 52(6):453-463. PubMed ID: 33067739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of Nrf2 Signalling and the Inhibition of Erastin-Induced Ferroptosis by Ferulic Acid in MIN6 Cells.
    Kose T; Sharp PA; Latunde-Dada GO
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Actin-like protein 6A is a novel prognostic indicator promoting invasion and metastasis in osteosarcoma.
    Sun W; Wang W; Lei J; Li H; Wu Y
    Oncol Rep; 2017 Apr; 37(4):2405-2417. PubMed ID: 28260090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actl6a protects embryonic stem cells from differentiating into primitive endoderm.
    Lu W; Fang L; Ouyang B; Zhang X; Zhan S; Feng X; Bai Y; Han X; Kim H; He Q; Wan M; Shi FT; Feng XH; Liu D; Huang J; Songyang Z
    Stem Cells; 2015 Jun; 33(6):1782-93. PubMed ID: 25802002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACTL6A interacts with p53 in acute promyelocytic leukemia cell lines to affect differentiation via the Sox2/Notch1 signaling pathway.
    Zhong PQ; Zhong L; Yao JJ; Liu DD; Yuan Z; Liu JM; Chen M; Yao SF; Zhao Y; Liu L; Li LW; Liu BZ
    Cell Signal; 2019 Jan; 53():390-399. PubMed ID: 30448346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ferroptosis is induced by lenvatinib through fibroblast growth factor receptor-4 inhibition in hepatocellular carcinoma.
    Iseda N; Itoh S; Toshida K; Tomiyama T; Morinaga A; Shimokawa M; Shimagaki T; Wang H; Kurihara T; Toshima T; Nagao Y; Harada N; Yoshizumi T; Mori M
    Cancer Sci; 2022 Jul; 113(7):2272-2287. PubMed ID: 35466502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.